Erratum: APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer's Disease Phenotypes in Human iPSC-Derived Brain Cell Types (Neuron (2018) (S0896627318303805) (10.1016/j.neuron.2018.05.008));APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer's Disease Phenotypes in Human iPSC-Derived Brain Cell Types

Neuron

Volumn 98, Issue 6, 2018, Pages 1141-1154.e7

  Lin, Yuan Ta ^a   Seo, Jinsoo ^a,d   Gao, Fan ^a   Feldman, Heather M ^b   Wen, Hsin Lan ^a   Penney, Jay ^a   Cam, Hugh P ^a   Gjoneska, Elizabeta ^a   Raja, Waseem K ^a   Cheng, Jemmie ^a   Rueda, Richard ^a   Kritskiy, Oleg ^a   Abdurrob, Fatema ^a   Peng, Zhuyu ^a   Milo, Blerta ^a   Yu, Chung Jong ^a,c   Elmsaouri, Sara ^a   Dey, Dilip ^a   Ko, Tak ^a   Yankner, Bruce A ^b   Tsai, Li Huei ^a   more..

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD UNIVERSITY   (United States)

^d Daegu Gyeongbuk Institute of Science and Technology   (South Korea)

Author keywords

Alzheimer's disease; APOE; A ; A uptake; cerebral organoids; cholesterol; CRISPR Cas9; early endosomes; immune response; iPSC

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; TAU PROTEIN; TRANSCRIPTOME; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); MAPT PROTEIN, HUMAN; PEPTIDE FRAGMENT; PHOSPHOPROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL CELL; APOE4 GENE; ARTICLE; ASTROCYTE; BRAIN CELL; CAUSAL ATTRIBUTION; CONTROLLED STUDY; CRISPR-CAS9 SYSTEM; DISEASE ASSOCIATION; EMBRYO; ENDOSOME; FEMALE; GENE EXPRESSION; GENE SEQUENCE; GENETIC VARIATION; GLIA CELL; HOMOZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INDUCED PLURIPOTENT STEM CELL; LIPID METABOLISM; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; SYNAPSE; BRAIN; CELL DIFFERENTIATION; CRISPR CAS SYSTEM; CYTOLOGY; GENETICS; GLIA; IMMUNOLOGY; METABOLISM; MICROGLIA; NERVE CELL; ORGANOID; SYNAPTIC TRANSMISSION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ASTROCYTES; BRAIN; CELL DIFFERENTIATION; CRISPR-CAS SYSTEMS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LIPID METABOLISM; MICROGLIA; NEUROGLIA; NEURONS; ORGANOIDS; PEPTIDE FRAGMENTS; PHOSPHOPROTEINS; SYNAPTIC TRANSMISSION; TAU PROTEINS; TRANSCRIPTOME;

EID: 85047327738     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2018.06.011     Document Type: Erratum

References (70)

1. Alvarez, X.A., Alvarez, I., Iglesias, O., Crespo, I., Figueroa, J., Aleixandre, M., Linares, C., Granizo, E., Garcia-Fantini, M., Marey, J., et al. Synergistic increase of serum BDNF in Alzheimer patients treated with cerebrolysin and donepezil: association with cognitive improvement in ApoE4 cases. Int. J. Neuropsychopharmacol. 12 (2016), 1–10.
2. Alzheimer's Association. 2016 Alzheimer's disease facts and figures. Alzheimers Dement. 12 (2016), 459–509.
3. Bero, A.W., Yan, P., Roh, J.H., Cirrito, J.R., Stewart, F.R., Raichle, M.E., Lee, J.-M., Holtzman, D.M., Neuronal activity regulates the regional vulnerability to amyloid-β deposition. Nat. Neurosci. 14 (2011), 750–756.
4. Busskamp, V., Lewis, N.E., Guye, P., Ng, A.H.M., Shipman, S.L., Byrne, S.M., Sanjana, N.E., Murn, J., Li, Y., Li, S., et al. Rapid neurogenesis through transcriptional activation in human stem cells. Mol. Syst. Biol., 10, 2014, 760.
5. Calcoen, D., Elias, L., Yu, X., What does it take to produce a breakthrough drug?. Nat. Rev. Drug Discov. 14 (2015), 161–162.
6. Canter, R.G., Penney, J., Tsai, L.H., The road to restoring neural circuits for the treatment of Alzheimer's disease. Nature 539 (2016), 187–196.
7. Cataldo, A.M., Peterhoff, C.M., Troncoso, J.C., Gomez-Isla, T., Hyman, B.T., Nixon, R.A., Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am. J. Pathol. 157 (2000), 277–286.
8. Chen, J., Bardes, E.E., Aronow, B.J., Jegga, A.G., ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res., 37, 2009 W305-11.
9. Chen, C., Jiang, P., Xue, H., Peterson, S.E., Tran, H.T., McCann, A.E., Parast, M.M., Li, S., Pleasure, D.E., Laurent, L.C., et al. Role of astroglia in Down's syndrome revealed by patient-derived human-induced pluripotent stem cells. Nat. Commun., 5, 2014, 4430.
10. Cheng, H., Vetrivel, K.S., Gong, P., Meckler, X., Parent, A., Thinakaran, G., Mechanisms of disease: new therapeutic strategies for Alzheimer's disease—targeting APP processing in lipid rafts. Nat. Clin. Pract. Neurol. 3 (2007), 374–382.
11. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L., Pericak-Vance, M.A., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993), 921–923.
12. Crowe, E.P., Tuzer, F., Gregory, B.D., Donahue, G., Gosai, S.J., Cohen, J., Leung, Y.Y., Yetkin, E., Nativio, R., Wang, L.-S., et al. Changes in the transcriptome of human astrocytes accompanying oxidative stress-induced senescence. Front. Aging Neurosci., 8, 2016, 208.
13. Das, U., Scott, D.A., Ganguly, A., Koo, E.H., Tang, Y., Roy, S., Activity-induced convergence of APP and BACE-1 in acidic microdomains via an endocytosis-dependent pathway. Neuron 79 (2013), 447–460.
14. De Strooper, B., Karran, E., The cellular phase of Alzheimer's disease. Cell 164 (2016), 603–615.
15. Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., Gingeras, T.R., STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29 (2013), 15–21.
16. Efthymiou, A.G., Goate, A.M., Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk. Mol. Neurodegener., 12, 2017, 43.
17. Fu, H., Liu, B., Frost, J.L., Hong, S., Jin, M., Ostaszewski, B., Shankar, G.M., Costantino, I.M., Carroll, M.C., Mayadas, T.N., Lemere, C.A., Complement component C3 and complement receptor type 3 contribute to the phagocytosis and clearance of fibrillar Aβ by microglia. Glia 60 (2012), 993–1003.
18. Goldstein, J.L., DeBose-Boyd, R.A., Brown, M.S., Protein sensors for membrane sterols. Cell 124 (2006), 35–46.
19. Göritz, C., Mauch, D.H., Nägler, K., Pfrieger, F.W., Role of glia-derived cholesterol in synaptogenesis: new revelations in the synapse-glia affair. J. Physiol. Paris 96 (2002), 257–263.
20. Gosselin, D., Skola, D., Coufal, N.G., Holtman, I.R., Schlachetzki, J.C.M., Sajti, E., Jaeger, B.N., O'Connor, C., Fitzpatrick, C., Pasillas, M.P., et al. An environment-dependent transcriptional network specifies human microglia identity. Science, 356, 2017, 6344.
21. Heslegrave, A., Heywood, W., Paterson, R., Magdalinou, N., Svensson, J., Johansson, P., Öhrfelt, A., Blennow, K., Hardy, J., Schott, J., et al. Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease. Mol. Neurodegener., 11, 2016, 3.
22. Holtzman, D.M., Bales, K.R., Wu, S., Bhat, P., Parsadanian, M., Fagan, A.M., Chang, L.K., Sun, Y., Paul, S.M., Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease. J. Clin. Invest. 103 (1999), R15–R21.
23. Huang, Y.A., Zhou, B., Wernig, M., Südhof, T.C., ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and Aβ secretion. Cell 168 (2017), 427–441.e21.
24. Iaccarino, H.F., Singer, A.C., Martorell, A.J., Rudenko, A., Gao, F., Gillingham, T.Z., Mathys, H., Seo, J., Kritskiy, O., Abdurrob, F., et al. Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature 540 (2016), 230–235.
25. Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T.K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. A unique microglia type associated with restricting development of Alzheimer's disease. Cell 169 (2017), 1276–1290.e17.
26. Kim, J., Basak, J.M., Holtzman, D.M., The role of apolipoprotein E in Alzheimer's disease. Neuron 63 (2009), 287–303.
27. Koistinaho, M., Lin, S., Wu, X., Esterman, M., Koger, D., Hanson, J., Higgs, R., Liu, F., Malkani, S., Bales, K.R., Paul, S.M., Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat. Med. 10 (2004), 719–726.
28. Lambert, J.C., Ibrahim-Verbaas, C.A., Harold, D., Naj, A.C., Sims, R., Bellenguez, C., DeStafano, A.L., Bis, J.C., Beecham, G.W., Grenier-Boley, B., et al. European Alzheimer's Disease Initiative (EADI) Genetic and Environmental Risk in Alzheimer's Disease Alzheimer's Disease Genetic Consortium, Cohorts for Heart and Aging Research in Genomic Epidemiology. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat. Genet. 45 (2013), 1452–1458.
29. Langfelder, P., Horvath, S., WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics, 9, 2008, 559.
30. Li, H., Durbin, R., Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26 (2010), 589–595.
31. Liao, F., Hori, Y., Hudry, E., Bauer, A.Q., Jiang, H., Mahan, T.E., Lefton, K.B., Zhang, T.J., Dearborn, J.T., Kim, J., et al. Anti-ApoE antibody given after plaque onset decreases Aβ accumulation and improves brain function in a mouse model of Aβ amyloidosis. J. Neurosci. 34 (2014), 7281–7292.
32. Liao, Y., Smyth, G.K., Shi, W., featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30 (2014), 923–930.
33. Liu, C.-C., Liu, C.-C., Kanekiyo, T., Xu, H., Bu, G., Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9 (2013), 106–118.
34. Liu, Y.-H., Jiao, S.-S., Wang, Y.-R., Bu, X.-L., Yao, X.-Q., Xiang, Y., Wang, Q.-H., Wang, L., Deng, J., Li, J., et al. Associations between ApoEε4 carrier status and serum BDNF levels—new insights into the molecular mechanism of ApoEε4 actions in Alzheimer's disease. Mol. Neurobiol. 51 (2015), 1271–1277.
35. Marquer, C., Laine, J., Dauphinot, L., Hanbouch, L., Lemercier-Neuillet, C., Pierrot, N., Bossers, K., Le, M., Corlier, F., Benstaali, C., et al. Increasing membrane cholesterol of neurons in culture recapitulates Alzheimer's disease early phenotypes. Mol. Neurodegener., 9, 2014, 60.
36. Masuda, T., Tsuda, M., Yoshinaga, R., Tozaki-Saitoh, H., Ozato, K., Tamura, T., Inoue, K., IRF8 is a critical transcription factor for transforming microglia into a reactive phenotype. Cell Rep. 1 (2012), 334–340.
37. Mathys, H., Adaikkan, C., Gao, F., Young, J.Z., Manet, E., Hemberg, M., De Jager, P.L., Ransohoff, R.M., Regev, A., Tsai, L.H., Temporal tracking of microglia activation in neurodegeneration at single-cell resolution. Cell Rep. 21 (2017), 366–380.
38. Mauch, D.H., Nägler, K., Schumacher, S., Göritz, C., Müller, E.C., Otto, A., Pfrieger, F.W., CNS synaptogenesis promoted by glia-derived cholesterol. Science 294 (2001), 1354–1357.
39. McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., DePristo, M.A., The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20 (2010), 1297–1303.
40. Mooijaart, S.P., Berbée, J.F.P., van Heemst, D., Havekes, L.M., de Craen, A.J.M., Slagboom, P.E., Rensen, P.C.N., Westendorp, R.G.J., ApoE plasma levels and risk of cardiovascular mortality in old age. PLoS Med., 3, 2006, e176.
41. Muffat, J., Li, Y., Yuan, B., Mitalipova, M., Omer, A., Corcoran, S., Bakiasi, G., Tsai, L.H., Aubourg, P., Ransohoff, R.M., Jaenisch, R., Efficient derivation of microglia-like cells from human pluripotent stem cells. Nat. Med. 22 (2016), 1358–1367.
42. Olsson, A., Venkatasubramanian, M., Chaudhri, V.K., Aronow, B.J., Salomonis, N., Singh, H., Grimes, H.L., Single-cell analysis of mixed-lineage states leading to a binary cell fate choice. Nature 537 (2016), 698–702.
43. Paquet, D., Kwart, D., Chen, A., Sproul, A., Jacob, S., Teo, S., Olsen, K.M., Gregg, A., Noggle, S., Tessier-Lavigne, M., Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature 533 (2016), 125–129.
44. Quadrato, G., Nguyen, T., Macosko, E.Z., Sherwood, J.L., Min Yang, S., Berger, D.R., Maria, N., Scholvin, J., Goldman, M., Kinney, J.P., et al. Cell diversity and network dynamics in photosensitive human brain organoids. Nature 545 (2017), 48–53.
45. Raja, W.K., Mungenast, A.E., Lin, Y.-T., Ko, T., Abdurrob, F., Seo, J., Tsai, L.-H., Self-organizing 3D human neural tissue derived from induced pluripotent stem cells recapitulate Alzheimer's disease phenotypes. PLoS ONE, 11, 2016, e0161969.
46. Ran, F.A., Hsu, P.D., Wright, J., Agarwala, V., Scott, D.A., Zhang, F., Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8 (2013), 2281–2308.
47. Robinson, M.D., McCarthy, D.J., Smyth, G.K., edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26 (2010), 139–140.
48. Robinson, J.T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E.S., Getz, G., Mesirov, J.P., Integrative genomics viewer. Nat. Biotechnol. 29 (2011), 24–26.
49. Salter, M.W., Beggs, S., Sublime microglia: expanding roles for the guardians of the CNS. Cell 158 (2014), 15–24.
50. Sarlus, H., Heneka, M.T., Microglia in Alzheimer's disease. J. Clin. Invest. 127 (2017), 3240–3249.
51. Seipel, K., O'Brien, S.P., Iannotti, E., Medley, Q.G., Streuli, M., Tara, a novel F-actin binding protein, associates with the Trio guanine nucleotide exchange factor and regulates actin cytoskeletal organization. J. Cell Sci. 114 (2001), 389–399.
52. Shabalin, A.A., Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics 28 (2012), 1353–1358.
53. Shahin, H., Walsh, T., Sobe, T., Abu Sa'ed, J., Abu Rayan, A., Lynch, E.D., Lee, M.K., Avraham, K.B., King, M.-C., Kanaan, M., Mutations in a novel isoform of TRIOBP that encodes a filamentous-actin binding protein are responsible for DFNB28 recessive nonsyndromic hearing loss. Am. J. Hum. Genet. 78 (2006), 144–152.
54. Shi, Y., Yamada, K., Liddelow, S.A., Smith, S.T., Zhao, L., Luo, W., Tsai, R.M., Spina, S., Grinberg, L.T., Rojas, J.C., et al., Alzheimer's Disease Neuroimaging Initiative. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549 (2017), 523–527.
55. Sidoryk-Wegrzynowicz, M., Wegrzynowicz, M., Lee, E., Bowman, A.B., Aschner, M., Role of astrocytes in brain function and disease. Toxicol. Pathol. 39 (2011), 115–123.
56. Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S., Roses, A.D., Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90 (1993), 1977–1981.
57. Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S., Mesirov, J.P., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102 (2005), 15545–15550.
58. Theendakara, V., Peters-Libeu, C.A., Spilman, P., Poksay, K.S., Bredesen, D.E., Rao, R.V., Direct transcriptional effects of Apolipoprotein E. J. Neurosci. 36 (2016), 685–700.
59. Toh, W.H., Gleeson, P.A., Dysregulation of intracellular trafficking and endosomal sorting in Alzheimer's disease: controversies and unanswered questions. Biochem. J. 473 (2016), 1977–1993.
60. Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D.R., Pimentel, H., Salzberg, S.L., Rinn, J.L., Pachter, L., Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7 (2012), 562–578.
61. Ulrich, J.D., Holtzman, D.M., TREM2 function in Alzheimer's disease and neurodegeneration. ACS Chem. Neurosci. 7 (2016), 420–427.
62. Wang, K., Li, M., Hakonarson, H., ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res., 38, 2010, e164.
63. Wang, C., Najm, R., Xu, Q., Jeong, D.E., Walker, D., Balestra, M.E., Yoon, S.Y., Yuan, H., Li, G., Miller, Z.A., et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat. Med., 2018, 10.1038/s41591-018-0004-z.
64. Wyss-Coray, T., Loike, J.D., Brionne, T.C., Lu, E., Anankov, R., Yan, F., Silverstein, S.C., Husemann, J., Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat. Med. 9 (2003), 453–457.
65. Xu, Q., Bernardo, A., Walker, D., Kanegawa, T., Mahley, R.W., Huang, Y., Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J. Neurosci. 26 (2006), 4985–4994.
66. Zhang, Y., Liu, T., Meyer, C.A., Eeckhoute, J., Johnson, D.S., Bernstein, B.E., Nusbaum, C., Myers, R.M., Brown, M., Li, W., Liu, X.S., Model-based analysis of ChIP-seq (MACS). Genome Biol., 9, 2008, R137.
67. Zhang, Y., Pak, C., Han, Y., Ahlenius, H., Zhang, Z., Chanda, S., Marro, S., Patzke, C., Acuna, C., Covy, J., et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78 (2013), 785–798.
68. Zhang, L., Fang, Y., Lian, Y., Chen, Y., Wu, T., Zheng, Y., Zong, H., Sun, L., Zhang, R., Wang, Z., Xu, Y., Brain-derived neurotrophic factor ameliorates learning deficits in a rat model of Alzheimer's disease induced by aβ1-42. PLoS ONE, 10, 2015, e0122415.
69. Zhang, Y., Sloan, S.A., Clarke, L.E., Caneda, C., Plaza, C.A., Blumenthal, P.D., Vogel, H., Steinberg, G.K., Edwards, M.S.B., Li, G., et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 89 (2016), 37–53.
70. Zhao, J., Davis, M.D., Martens, Y.A., Shinohara, M., Graff-Radford, N.R., Younkin, S.G., Wszolek, Z.K., Kanekiyo, T., Bu, G., APOE ε4/ε4 diminishes neurotrophic function of human iPSC-derived astrocytes. Hum. Mol. Genet. 26 (2017), 2690–2700.